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ABSTRACT Aquagenic urticaria (AQ) is a rare physical urticaria induced by contact 
with water. It may be distinctive clinically, evident as 1-2 mm folliculopapular urti-
caria, a pattern also characteristic of cholinergic urticaria. AQ has a truncal and up-
per extremity distribution within 20-30 minutes after contact with water, regardless 
of its temperature or source. AQ is usually symptomatic with mild to severe pruritus 
and a burning sensation. The mechanism by which water produces mast cell de-
granulation and histamine release remains unclear. We review its clinical presenta-
tion, diagnostic parameters, differential diagnosis, and treatment. 
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INTRODUCTION
Aquagenic urticaria is a type of physical urticaria 
produced by contact with water. It was first described 
in 1964 as a reaction to a toxic component of water, 
leading to mast cell degranulation and urticaria (1). 
Further hypotheses regarding the cause of this ur-
ticaria include acetylcholine propagated histamine 
release and mast cell degranulation secondary to epi-
dermal antigen diffusion into the dermis upon con-
tact with water (2,3). However, when histamine levels 
are measured before and after water challenge with 
aquagenic urticaria, histamine levels may remain 
within normal limits and symptoms may not be pre-
vented with the use of anthistamines or anticholiner-
gics (4). In this review of aquagenic urticaria, we will 
describe its various clinical presentations, diagnostic 
assessments, differential diagnoses, and treatments. 
CLINICAL PRESENTATION AND DIAGNOSIS
Aquagenic urticaria is produced when water 
comes into contact with the epidermis. Urticaria is 
produced irrespective of water temperature, pH, or 
psychogenic factors (5,6). Incidence is slightly greater 
in women than in men; onset is usually on or around 
puberty. Approximately 100 cases have been report-
ed in the literature (6). In general, wheals are seen 
within 20-30 minutes of aqueous contact and sub-
side 30-60 minutes after water is removed. Alcohol 
or other organic solutions do not cause an urticarial 
reaction, but can propagate the effect of water by en-
hancing its permeability through skin (6) Shelley and 
Rawnsley (1) first described this entity as primarily 
1-2 mm folliculopapular urticaria with a truncal and 
upper extremity distribution, associated with mild to 
severe pruritus and burning (Figure 1). 
Clinical criteria that needed for this diagnosis 
include elimination of other physical urticarias as a 
cause of symptomatology and a positive response 
to a water provocation test (6).The standard water 
provocation test is a 30-minute application of water 
compresses at 35 degrees Celsius; however, local ap-
plication of water to other areas following negative 
compress testing can also be done (4,6-8). While ur-
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ticaria can be induced by water of any temperature, 
maintaining the water at room temperature aids in 
differentiating aquagenic urticaria from cold-induced 
or local heat urticaria (9). In addition, the compress 
test is often done on the upper body as opposed to 
the extremities because the extremities are less fre-
quently affected by aquagenic urticaria (6). This test 
is considered positive if pruritic hives are noted in the 
tested area. Familial associations have been noted, 
with one case of monozygotic twins both having 
aquagenic urticaria; however, no specific gene lo-
cus has been identified and most reported cases are 
sporadic (6,10). One cases series described the asso-
ciation of aquagenic urticaria and lactose intolerance 
over three generations as a possible gene loci asso-
ciation (11). A family history of atopy has occasionally 
but not consistently been reported among those af-
fected (6). Other symptoms sometimes noted in asso-
ciation with physical urticaria upon contact with wa-
ter include headache, wheezing, shortness of breath, 
and dizziness (4,11). Routine laboratory values includ-
ing erythrocyte sedimentation rate, complete blood 
count, total eosinophil count, glucose, electrolytes, 
liver and kidney function tests, and immunoglobulins 
including IgE, anti-nuclear antibodies, cryoglobulins, 
VDRL, cold agglutinins, and complement levels are 
usually all within normal range (7,12). 
DIFFERENTIAL DIAGNOSIS
Aquagenic urticaria must be differentiated from 
other physical urticarias, particularly from cholinergic 
urticaria and aquagenic pruritus. A thorough history 
and physical examination with a focus on factors that 
trigger urticaria and specialized in-office procedures 
help to eliminate other causes on the differential di-
agnosis list. Aquagenic and cholinergic urticaria are 
identical clinically; differentiation of the two is based 
upon inciting factors. Cholinergic urticaria can be in-
duced by exercise, sweating, heat, and emotion while 
aquagenic urticaria is limited to water-induced lesions 
only (6). Various physical exam findings can also help 
differentiate aquagenic urticaria from other physical 
urticarias. To differentiate from delayed pressure-in-
duced urticaria, one can apply a weight of 0.2-1.5 kg/
cm2 to a localized area for 20 minutes and observe for 
any wheels after its removal (9). Solar urticaria can be 
tested for by exposing skin to varying wavelengths of 
ultraviolet and visible light; dermatographic urticaria 
can be elicited simply by performing maneuvers that 
induce dermatographism, such as a stroke test. Con-
tact urticaria can be identified by performing a prick 
test and then observing for wheal formation over a 
20-minute period (9). Cold-induced urticaria can be 
tested for by applying an ice pack to a localized area 
Table 1. The differential diagnoses to be considered when evaluating a patient for aquagenic urticaria
Differential diagnosis    History and physical exam findings
Cholinergic urticaria Induced by exercise, sweat, heat, emotion
Sweat-induced: perform exercise that induces sweating and observe for urti-
caria formation
Localized heat-induced: compress test with compress soaked in hot water 
Delayed pressure-induced urticaria Apply a weight of 0.2-15 kg/cm2 to a localized area for 20 minutes and after its 
removal observe for any urticaria
Solar urticaria Expose skin to varying wavelengths of ultraviolet and visible light and observe 
for urticaria
Dermatographic urticaria Perform maneuvers that induce dermatographism and observe for urticaria
Cold-induced urticaria Apply an ice pack to a localized area for 20 minutes and observe for any hive or 
wheal formation
Contact-induced urticaria Perform a prick test and then document for wheal formation over a 20 minute 
period
Aquagenic pruritus Elicit pruritus upon exposure to water but no hive formation
Figure 1. Multiple folliculopapular wheals on the back of 
a 25-year-old woman affected by aquagenic urticaria. Le-
sions are extremely pruritic and appeared following a luke-
warm shower.
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for 20 minutes and observing for any wheal forma-
tion (9,10). Having the patient perform activities 
that induce sweating and then observing them for 
a period of time can aid in differentiating aquagenic 
from sweat-induced urticaria (6). Cholinergic urticaria 
is traditionally tested via exercise, but it can also be 
evaluated by intradermally injecting either 0.05 mL of 
0.002% carbamylcholine chloride (carbachol) or 0.05 
mL of 0.02% (0.01 mg) methacholine and observ-
ing for any wheals, which are usually seen in 51% of 
subjects (15). Aquagenic pruritus is characterized by 
pruritus upon exposure to water, but lacks the char-
acteristic hive formation seen in aquagenic urticaria 
(6) (Table 1). 
TREATMENT
Pre-exposure nonsedating, second-generation H1 
antihistamines are a first-line treatment and have had 
effects varying from complete symptom control to no 
response (6,7,10,14). Dosing amounts vary; doses up 
to four times the amount of the standard daily dose 
have been administered (10). A minority of cases are 
resistant to anti-histamines and other anecdotal ther-
apies. PUVA and UVB may control symptoms in pa-
tients resistant to antihistamines (15-18). Ultraviolet 
light may alleviate symptoms of aquagenic urticaria 
by thickening the epidermis and thus prevent the pen-
etration of water (15). Combination PUVA and antihis-
tamines have also been used. In one instance, PUVA 
therapy was begun in an antihistamine resistant case 
with methoxsalen 0.6 mg/kg four times a week with 
a starting UVA level of 3 J/cm2, which was gradually 
increased by 1 J/cm2 until a maximum dose of 12 J/
cm2 was reached. After two weeks, new wheal forma-
tion had ceased; however, the patient was still pruritic 
with water contact, which was confirmed by a water 
provocation test. After 20 sessions, the patient started 
receiving PUVA only once weekly, and two weeks lat-
er new lesions were noted. Astemizole 10 mg/day was 
then added to her regimen and all symptoms cleared 
(16). PUVA may theoretically offer benefits through 
epidermal thickening. In one case of antihistamine-
resistant aquagenic urticaria in a patient with HIV, 
stanazolol 10 mg/day treatment was successful in re-
solving the symptomatology (19). Barrier creams have 
also been used as treatment for aquagenic urticaria. 
These topical agents prevent water contact with the 
skin by creating a barrier with a hydrophobic agent 
such as petrolatum (15). Barrier creams have varying 
efficacy, providing complete avoidance of symptoms 
in some cases while only allowing for prolonged ex-
posure to water before the development of hives in 
others (2,15,20). Omalizumab, a recombinant anti-IgE 
antibody, may be used in selected patients (21).
CONCLUSION
With only 100 cases reported in the literature, 
aquagenic urticaria is a rare yet potentially debilitat-
ing form of physical urticaria (6). While the complete 
pathogenesis of this entity has not been fully eluci-
dated, the role of histamine appears to be central. 
Accordingly, nonsedating, second-generation H1 
antihistamines have emerged as the gold standard 
of treatment (6,7,10,14). In the antihistamine-resis-
tant patient, barrier creams and stanzolol may show 
efficacy, as may the recombinant humanized mono-
clonal anti-IgE antibody omalizumab (2,15-21). The 
presence of these resistant cases indicates that an-
other underlying factor is contributing to aquagenic 
urticaria. Further research into this factor will help in 
generating better clinical treatments.
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